Stephen N. Oesterle
CIK 1174532 · SrVP Medicine & Technology · last filed 2025-05-08
Stephen N. Oesterle is a SrVP Medicine & Technology who has filed 35 SEC Form 4 insider transactions across 5 companies since 2007. The most recent filing, for BAX, was dated May 8, 2025. Across all open-market trades the lifetime net is −$694.3K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $4.9M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$4.93M
5
35
-$694.3K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| BAX | Director | 35,847 | $20.86 | $747.8K | $0 | 10 | 2025-05-08 |
| Paragon 28, Inc. (FNA) Delisted | Director | 0 | $13.09 | $0 | $0 | 5 | 2025-04-21 |
| Sigilon Therapeutics, Inc. (SGTX) Delisted | Director | — | $22.47 | — | $0 | 5 | 2023-08-11 |
| HeartWare International, Inc. (HTWR) Delisted | Director | 0 | — | — | $32.2K | 4 | 2016-08-24 |
| MDT | SrVP Medicine & Technology | 52,209 | $80.20 | $4.19M | -$726.5K | 9 | 2009-08-05 |
Recent Filings
35 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-05-08 | BAX | Grant (A) | +7,183 | $0 | EDGAR |
| 2025-04-21 | Paragon 28, Inc. (FNA) Delisted | Disp (D) | −40,216 | $0 | EDGAR |
| 2024-05-21 | Paragon 28, Inc. (FNA) Delisted | Grant (A) | +15,906 | $0 | EDGAR |
| 2024-05-09 | BAX | Grant (A) | +5,952 | $0 | EDGAR |
| 2023-08-11 | Sigilon Therapeutics, Inc. (SGTX) Delisted | Disp (D) | — | $0 | EDGAR |
| 2023-05-22 | Sigilon Therapeutics, Inc. (SGTX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-05-19 | Paragon 28, Inc. (FNA) Delisted | Grant (A) | +8,361 | $0 | EDGAR |
| 2023-05-04 | BAX | Grant (A) | +4,573 | $0 | EDGAR |
| 2023-02-22 | Paragon 28, Inc. (FNA) Delisted | Grant (A) | +8,918 | $0 | EDGAR |
| 2022-05-27 | Sigilon Therapeutics, Inc. (SGTX) Delisted | Grant (A) | — | $0 | EDGAR |